Desiree Perez Brings a Lot to Roc Nation

The rise of Roc Nation is something that people cannot overlook. Desiree Perez has been doing her best to take this company to another level, and that is the reason that the company is thriving. She has become a leader at Roc Nation, and this has allowed her to connect many artists and athletes to great contracts. People like Skylar Diggins Smith are getting great contracts in sports. Perez is the reason that underground artists like Bobby Raps and Claudia Leitte are getting more exposure. The Roc Nation list of artists are growing and Desiree Perez is in place to oversee all the changes.

Perez is giving Jay-Z what he needs. Desiree Perez is someone that has managed to pick up the pace when it comes to growing the roster at Roc Nation. Jay-Z would not have the time that he needed to actually manage Roc Nation the way he would have wanted to. It took someone like Desiree Perez that is willing to take the time to concentrate on every aspect of the business. She knows what is going on with the artists, and she has her hands inside of the contract negotiations. She is touching up on every aspect of Roc Nation, and she is helping Jay-Z build the type of company that he wanted to see.

There is a lot of young talent that comes through right nation, and all of these young artists need guidance from someone that has been in the business long enough to know what is going on. Desiree one of those people that knows the ropes and she knows how to navigate in the entertainment and the sports world. She knows about the contracts and how to negotiate better contracts for these young artists that are just starting to learn the ropes.

Twitter: https://twitter.com/desireeperez01

NuoDB offers SQL databases built for the cloud

NuoDB is a technology company leading the way to a new generation of SQL databases, specially built and architected for cloud computing.

NuoDB’s chief product is support for elastic SQL databases that can scale up alongside other cloud-hosted resources. With elastic SQL databases, data can be distributed across many cloud servers without any decline in performance. In addition, they use the same familiar scripting language as traditional SQL databases.

NuoDB offers several advantages over traditional relational databases and NoSQL databases. NuoDB’s product can scale on-demand faster and easier than other types of SQL databases. Performance of NuoDB is incredibly consistent thanks to its approach to cloud replication. Also, NuoDB can support a range of cloud deployments, including private, public, or hybrid.

With the efficiency offered by NuoDB over traditional SQL databases, users will see lowered infrastructure costs, lower application development costs, and new market opportunities. NuoDB offers multiple ways to trial their services, allowing prospective customers to see how their SQL databases could be migrated to the NuoDB solution.

Mikhail Blagosklonny and the Newest Multifunctional Drug

As medicine advances, discoveries are made that surpass the expectations of many physicians around the world. What was thought to be impossible centuries ago is no longer a matter of debate for our modern medicine. That shows how much society has evolved in that regard.One of the biggest areas of medicine that show exponential growth in its discoveries in Oncology, and the physician, scientist and doctor Mikhail Blagosklonny is one of the key players in the biggest innovations of the last decade.Being a professor at the Rosewell Park Cancer Institute in Buffalo, he teaches Oncology at the institute, be it to young students, adults and seniors alike.He is also famous for his work with Oncotarget, the biggest online news platform and the most influential one in the Oncology area. When scientists are researching for the latest news on this front, Oncotarget is one of the first sources to trust. Mikhail Blagosklonny, being the Editor-in-Chief of the platform, is responsible for the news that appears in the outlets and articles.

Rapamycin, a drug that was commonly used to prevent organ transplant rejection, is currently one of the hottest news in the Oncology field. Mikhail Blagosklonny found out that this remedy has many more uses to the humanity than just to help transplants occur successfully without the body rejecting the new organ. The Rapamycin has regenerative traits that were never noticed before Mikhail Blagosklonny’s research.With extensive research being conducted by Blagosklonny on the subject of aging, he has noticed that the remedy could be used to decelerate the effects of aging. Yes, that is right, Mikhail Blagosklonny was about to discover what is being called around the world as the anti-aging drug.Being initially a cancer drug, now Rapamycin, also called Sirolimus, could be used to prevent diseases like cancer, which get more common with the process of aging. With a method that the scientist called a TOR-Centric model, he is now conducting a research trying to find the many possible ways that the drug can be used to make aging a much more bearable and healthy process.

Apart from that, the drug has also been found to be particularly useful with many other types of cancer treatments as well. It was discovered that it could be used to treat Lymphangioleiomyomatosis, hemolytic-uremic syndrome, Tuberous Sclerosis Complex, and, of course, cancer.It is believed that it can also be used to treat Alzheimer’s, but that research is still in progress, even though it is showing great results.Mikhail Blagosklonny still believes that the biggest and most influential use of the drug is still the possibility of increasing the longevity of the patient. The tests began with mice, and now they’ve switched to monkeys. The scientist behind all of this research firmly believes that Rapamycin can extend the lifespan of a human being just because of the results that have been obtained for the past years studying the drug.Many more uses are slowly showing up for the Rapamycin, like the possibility of treating Muscular Dystrophy, and all of these discoveries are making Mikhail Blagosklonny one of the most influential scientists of our century.